论文部分内容阅读
目的:探析康复新液对宫颈癌急性放射性肠炎的预防效果。方法:选取2014年1月-2015年1月我院收治的86例宫颈癌急性放射性肠炎患者为研究资料,按患者意愿将其分为两组,各43例。对照组采用放射治疗,观察组给予康复新液治疗,对比分析预防效果。结果:观察组的肠炎发生率为16.28%,低于对照组的53.49%(P<0.05);观察组的急性放射性肠炎发生时间优于对照组(P<0.05)。结论:宫颈癌急性放射性肠炎患者在放射治疗的基础上增加康复新液预防,可降低肠炎发生率,延长急性放射性肠炎的发生时间,值得在临床上进一步推广和应用。
Objective: To explore the preventive effect of Kangfuxin on acute radiation enteritis of cervical cancer. Methods: A total of 86 patients with acute radiation enterocolitis with cervical cancer who were admitted to our hospital from January 2014 to January 2015 were selected as the research materials, and were divided into two groups according to the wishes of the patients, 43 patients in each group. The control group was treated with radiotherapy, and the observation group was given Kangfuxinye treatment, comparing the prevention effect. Results: The incidence of enteritis in observation group was 16.28%, which was lower than that in control group (53.49%, P <0.05). The incidence of acute radiation enteritis in observation group was better than that in control group (P <0.05). Conclusion: The treatment of patients with acute radiation enteritis with cervical cancer should be treated with the new rehabilitation fluid, which can reduce the incidence of enteritis and prolong the occurrence of acute radiation enteritis. It is worth to be further popularized and applied clinically.